{"id":201765,"title":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T14:02:02.352000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html?wbdisable=false","snippet":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr /…","rawSnapshotUrl":"/api/snapshots/raw/201765","browseUrl":"https://replay.healtharchive.ca/job-1/20250419140202/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html?wbdisable=false#ha_snapshot=201765","mimeType":"text/html","statusCode":200}